Lv11
44 积分 2025-01-07 加入
Chapter 14 - Clinical Pathology in Nonclinical Toxicity Studies
5小时前
求助中
缓控释制剂非临床药代动力学研究与评价的考虑要点 CDE电子刊物/孙涛/CDE
1个月前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
1个月前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
1个月前
已完结
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement
1个月前
已完结
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement
1个月前
已关闭
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement
1个月前
已关闭
Interspecies scaling: prediction of human biliary clearance and comparison with QSPKR
1个月前
已完结
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050
1个月前
已完结
皖公网安备34019202002308
